earnings
confidence high
sentiment positive
materiality 0.75
Elevance Health Q2 diluted EPS $9.85 (+26% YoY); revenue $43.2B, down $0.2B
Elevance Health, Inc.
2024-Q2 EPS reported
$19.44
revenue$86,463,000,000
- Adjusted diluted EPS $10.12 (+12% YoY); GAAP EPS at least $34.05 for FY2024, adjusted at least $37.20.
- Health Benefits revenue $37.2B (-2%); Carelon revenue $13.3B (+10%) on risk-based service growth.
- Medical membership 45.8M, down 5% YoY due to Medicaid redeterminations; partly offset by ACA growth.
- Benefit expense ratio improved 10 bps to 86.3%; operating expense ratio increased to 11.7%.
- Q3 dividend $1.63/share declared, payable Sept 25, 2024; $3.2B share repurchase authorization remaining.